Elimination of potentially self-reactive T lymphocytes during their maturation in the thymus has been shown to be a major mechanism in accomplishing self-tolerance. Previous reports demonstrated that clonal deletion of self-Mls-l a -specific V,36+ T lymphocytes is controlled by a radiosensitive I-E+ thymic component. Irradiation chimeras reconstituted with I-E -bone marrow showed substantial numbers of mature V06+ T cells despite host MIS-1a expression. Analysis of the functional properties of such chimeric T cells revealed a surprising variability in their in vitro reactivity to host Mls-1a, depending on the H-2 haplotype of stem cells used for reconstitution. In chimeras reconstituted with B10.S (H-2') stem cells, mature Va6+ lymphocytes were present but functionally anergic to host-type Mls-1a in vitro. In contrast, in chimeras reconstituted with B10.G (H-29) bone marrow, nondeleted V)36+ cells were highly responsive to MIS-1a in vitro. These findings suggest that clonal anergy of V$6+ cells to selfMls-1a may be controlled by the affinity/avidity of T cell receptor interactions with bone marrow-derived cells in the thymus depending on the major histocompatibility complex class II molecules involved . Furthermore, chimeras bearing host (Mls-la)-reactive V06+ cells did not differ clinically from those with anergic or deleted V06+ cells and survived more than one year
mmunological tolerance to self determinants is thought to be accomplished by several distinct mechanisms. Recently, it has been shown that clonal deletion of self-specific T cells in the thymus is a major factor controlling autoreactivity of the immune system (1-11) . For example, mice of Mls-1a genotype have been found to clonally delete mature T cells expressing TCR V06, V08.1, V09, and V07, all four of which confer specificity to Mls-1a (2, 3, 11, 12) . The cellular basis of clonal deletion was further studied in irradiation bone marrow chimeras. V06+ T cells have been shown to be deleted independent of MIS-1a being expressed by donor or host tissue (6, 13) . This indicates that irradiated recipient mice express sufficient Mls-1a to tolerize immature lymphocytes. However, we (14, 15) and others (16) (17) (18) have demonstrated that deletion of V)36+ T cells in chimeras required MHC class II (I-E) expression on donor bone marrowderived cells, thus suggesting an important role for presentation of self-Mls-1 a by hemopoietic cells in the thymus.
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Besides clonal deletion, other mechanisms have been implicated in the maintenance of self-tolerance. Recently, T cells specific for (but not reactive to) self-antigens have been identified in immunized (19) , chimeric (16, 17, 20) , and transgenic (21) (22) (23) (24) (25) mice. This unresponsiveness (frequently referred to as anergy) was found among thymic and/or peripheral T lymphocytes ; however, the molecular basis of anergy remains obscure .
To investigate the mechanism(s) ofunresponsiveness in more detail, we took advantage of the fact that effective deletion of V06+ (Mls-la-specific) T cells in irradiation bone marrow chimeras depends upon the H-2 haplotype ofdonor stem tells used for reconstitution (14) (15) (16) (17) (18) . In particular, the functional properties of V06+ T cells that escaped clonal deletion were investigated and compared with T cells from chimeras where clonal deletion was effective. Lymphocytes from chimeras reconstituted with B10.S (I-E -) bone marrow cells responded very weakly to host-type Mls-1' stimulator cells, confirming other recent examples of clonal anergy (16, 17, 19, 20, 25) . In contrast, T cells from similar recipients reconstituted with B10.G (I-E') bone marrow reacted vigorously to host-type Mls-1' stimulator cells in vitro. These data indicate first that clonal anergy (at least in the Mls-1' system) is controlled by hemopoietic cells, and second, that T cell unresponsiveness in vivo may in some cases depend on mechanisms other than clonal anergy, e.g ., absence of appropriate antigen presentation in vivo.
Materials and Methods
Animals. Inbred DBA/2 (H-2d), BALB/c (H-2d), B10.D2 (H2d), B10.BR (H-2t .), and C57BL/6 (H-26) mice were purchased from the Institute fiir Zuchthygiene, Tierspital, University of Zurich, Switzerland . B10.G (H-29) and B10.S (H-2') mice were obtained from Olac, Bicester, Oxon, UK . BALRD2-Mls' (26) breeders were kindly provided by Dr. Hilliard Festenstein, London Hospital Medical College, UK . BALB.D2-Mls' (also referred to as BALRD2) and hybrid F, mice were bred locally. Characteristics of these strains relevant to the present study are summarized in Table 1 .
Chimeras. Bone marrow recipients were lethally radiated (950 rad, 117 rad/min, ,31Cs source) and reconstituted 1 d later with 2 x 10' T cell-depleted bone marrow cells (27) . For the following 8 wk, chloramphenicol (0 .4 g/liter) was added to the drinking water. The transplanted mice had a survival rate of 85-100%. Analysis was performedbetween 7 and 16 wk after reconstitution . Chimerism was monitoredby FACS analysis of lymph node or spleen cells with H-2 haplotype-specific mAbs.
Cytofluorographic Analysis. Aliquots of thymocytes or lymph node cells were stained at 4°C with rat mAbs 44-22-1 (V#6 specific) or KJ16-133 (VO&1/VS8.2 specific) followed by FITC-conjugated goat anti-rat IgG (Tago Inc., Burlingame, CA). PE-conjugated CD4-specific mAb GK 1.5 (Becton Dickinson & Co., Mountain Percentages of V06+/CD4+ lymph node cells (means of three individual mice) were determined by two-color immunofluorescence and are normalized to the total CD4+ populations .
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Tolerance to Mls-12 in Chimeras View, CA) was used for double staining. To assess the chimerism of transplanted mice, haplotype-specific mouse IgG2a mAbs 100-5.28 (KkDk specific, crossreactive with H-29), 342-12 (Dd specific), or 14 \ -`4 ' -4 (I-Ed,k specific), respectively, were used followed by a fluorescent goat anti-mouse IgG2areagent (Southern Biotechnology Associates, Inc., Birmingham, AL). Viable cells (20,000/sample) were analyzed by flow cytometry on a Epics Profile Analyzer (Coulter Electronics, Inc., Hialeah, FL) with logarithmic scales. Percentages after subtraction with the fluorescein conjugate alone are indicated.
Mixed Lymphocyte Cultures. Responder lymphocytes (1 .5 x 106) were incubated with irradiated (1,000 rad) anti Thy-1.2 (mAb AT 83) plus rabbit complement-depleted splenic stimulator cells (4.5 x 106) in 2 ml IMDM supplemented with 19 MM L-glutamine, 10 5 U/liter penicillin-streptomycin solution, 5 x 10 -s M 2-ME, and 10% heat-inactivated FCS in 24-well plates at 37°C in 5% COZ plus air. Cultures used for the assessment of ['Hlthymidine uptake and IL2 secretion contained 5 x 105 responder cells and 1-10 x 105 stimulator cells in 96-well flat-bottomed plates. In some experiments, responder populations were depleted of CD8 + cells by treatment with rat IgM mAb 3.168 .1 (CD8 specific) plus rabbit complement before culture.
IL2 Measurement . IL2 contents of 48-h MLC supernatants were assayed on CTLL2 cells as described (28) . IL2 values were calculated using OD 405-nm measurements after background subtraction . rIIL2 was used to calibrate a standard curve where 50% of the maximal OD 405-nm value was arbitrarily defined as 100 U of 11,2/ml. Consequently, 11,2 values were calculated as follows: 100 U/ml (dilution factor of sample supernatant at 50% max. OD)/(dilution factor at 50% max. OD of rIL2 standard). Growth of CTLL2 cells o£ MLC supernatants was completely blocked by the IL2-specific mAb S4B6, proving that the only factor measured was IL2 (some CTLL2 cells also show a minor sensitivity to IL4) .
Blast Purification. 3-d MLC-responding T cell blasts were isolated on a Percoll density gradient and resuspended (2 x 105 viable cells/ml) in fresh medium supplemented with human rIL2 (200
Mouse strain
Mls-1
ng/ml) . After 2 d, cells were recovered, counted, and analyzed for V/3 expression. Assessment ofMls-1' Stimulatory Capacity. Spleen cells (1-10 x 105) from chimeras and control mice were cocultured with the Mls-1'-specific T cell hybrid RG17.16 (2 x 104 cells) in 96-well flat-bottomed plates (29) . In some experiments, the stimulating spleen cells were irradiated with 1,000 rad and/or T cell depleted. No significant difference in stimulatory capacity was seen between these treatment protocols . 11,2 contents of supernatants were determined as described above.
Results
Chimeras Reconstituted with I-E -Bone Marrow Show Impaired Clonal Deletion of V(36+ T Cells. We constructed semiallogeneic parent -Ft chimeras using either B10.D2 (H-2d), B10.S (H-2S), or B10.G (H-2q) mice as donors of T cell-depleted bone marrow. Recipients were either (BALB.D2-Mls' x B10.S)Ft or (BALRD2-Mls' x B10.G)Ft mice. As shown in Table 2 Mls-1' mice were irradiated with 950 rad and reconstituted with T cell-depleted bone marrow from the indicated strains . Analysis was performed between 7 and 16 wk later. Means of three to four individual chimeras for V# expression are given as a proportion of the total CD4+ cells, respectively. Chimerism was assessed by H-2 expression. SDs ranged between 0.2 and 4 .7% .
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tained 6.8% of V06+ T cells among their peripheral CD4+ lymphocytes . Surprisingly, in initial analyses of the functional properties of chimeric T cells, we found strong host-specific reactivity. After stimulation with host-type DBA/2 (Mls-1') spleen cells, -30 U of IIr2/ml were produced (Table 3) . This response was specific for Mls-1' as shown by comparison of BAL&D2-Mls' vs. congenic BALB/c (Mls-16) stimulator cells. In contrast, lymphocytes from B10.D2 -DBA/2 chimeras containing very low levels of V06+ cells did not produce significant amounts of ID2 when stimulated with Mls-1' spleen cells. The control response after stimulation with third-party allogeneic MHC antigens was comparable for all cell populations. Thus, T cells from fully allogeneic chimeras reconstituted with I-E-/H-2q bone marrow cells exhibited reactivity to host Mls-1' .
Mls-1°-spec fic Reactivity of Chimeric Lymphocytes In Vitro
Depends on the H-2 Haplotype ofthe Bone Marrow Donor. While our studies were in progress, others published data from semiallogeneic parent -F1 chimeras using H-25 bone marrow cells (16, 17) . They demonstrated impaired clonal deletion of V/66+ cells similar to our findings, but reported on functional anergy ofMls-1'-specific T cells in their chimeras. Because this unresponsiveness of V#6+ cells was in contrast to the Mls-1'-specific reactivity in our system, we analyzed Mls-1a responsiveness of lymphocytes from parent -" F1 chimeras using either B10.S (H-2s) or B10.G (H-2q) donors. As demonstrated above ( Figure 1 . Mls-1=-specific 11,2 production of lymphocytes from semiallogeneic parent -+ F, bone marrow chimeras. Titrated T cell-depleted stimulator spleen cells of the indicated genotype were incubated with 5 x 105 responder lymphocyte from the indicated chimeras (a-t1) or control mice (e ands in 96-well plates for 48 h. Supernatants were assayed for 11,2 content. Data are means of triplicate cultures from two individual mice .
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Tolerance to Mls-la in Chimeras (BALB.D2-Mlsa x Bl0.S)Ft chimeras did not secrete IIr2 after stimulation with host-type MIS-la (BALB.D2-Mlsa x B10.S)Ft spleen cells, suggesting anergy of the V06+ cells found at levels of N5% in these animals. Interestingly, when lymphocytes from the same chimeras were stimulated with parental BALB.D2-Mlsa spleen cells, we detected weak proliferation and ti7 U of IIT2/ml MLC supernatant . As observed previously in fully allogeneic chimeras (Table 3) , B10.G --> (BALB.D2-Mlsa x B10.G)Ft chimeras showed reactivity to (BALB.D2-Mlsa x B10.G)Ft stimulators and were strongly reactive to BALB.D2-Mls a spleen cells . In summary, T cell responsiveness to host Mls-la was absent in chimeras reconstituted with MOM (I-E+) bone marrow, most probably due to clonal deletion of Mls-la-reactive cells. Furthermore, the Mls-la-specific response of chimeras reconstituted with B10 .S (I-E -) bone marrow was very low against BALB/D2-Mlsa stimulators, and no reactivity was found after stimulation with host-type (BALB.D2-Mlsa x B10 .S)Ft stimulator cells . In contrast, lymphocytes derived from chimeras reconstituted with B10.G (I-E-) bone marrow cells were clearly reactive to Mls-la presented by parental or Fl stimulators. MHC (I-E) Homozygous Mls-1°Stimulator Cells Induce Stronger T Cell Responses than Heterozygous Stimulators. As demonstrated in Fig. 1 , the Mls-la-specific activation of chimeric T cells was clearly higher when parental stimulator cells were used as compared with spleen cells derived from Fl hybrid mice. We reasoned that this discrepancy may have been due to a reduced MIS-la stimulatory capacity of F 1 hybrid cells. To test this, the Mls-1'-reactive V06+ T cell hybrid RG17.16 was incubated with the various stimulator spleen cells . As shown in Table 5 , the response to homozygous BALB.D2-Mls a cells was significantly higher when compared with heterozygous stimulators. In addition, we confirmed by flow cytometry that homozygous spleen cells expressed more I-E molecules than cells heterozygous at the MHC locus. Therefore, it is suggested that the decreased Mls-1' stimulatory capacity of spleen cells from Fl mice is due to their lower I-E expression. Additional experiments ruled out that heterozygosity at the Mls-1 locus by itself would Table 4 . SefA4h-1°-speck Proliferation of Lymphocytes from Semiallogeneic Parent -" F, Chimeras 5 x 105 irradiated (1,000 rad) T cell-depleted stimulator spleen cells were cultivated with 5 x 10 5 responder CD8 -thymocytes or lymph node cells from the chimeras or control mice indicated in 96-well plates and pulsed for the last 12 h of a 3-d incubation . The data (mean cpm x 10 -3 of three to four cultures after subtraction of background counts from cultures with responder cells alone) are from two chimeras of each group measured in a representative experiment . Underlined values are significantly (p < 0.05; student's t test) above background levels . SDs ranged between t 3 and ±32% for thymocyte responders, and between ± 4 and ± 37% for responders from lymph nodes. IL-2 values measured in supernatants of similar MLC are shown in Fig. 1 . significantly reduce antigenicity of stimulator cells, because spleen cells from (BALB.D2-Mls a x BALB/c)Fi were similarly Mls-12 stimulatory compared with BALB.D2-Mlsa cells (data not shown). Sf-Mls-1°-specfix In Vitro Proliferation of V06+ T Cells after Addition ofExogenous 11,2. We further investigated responsiveness of chimeric T cells by analyzing V06 expression in MLC after Mls-12 stimulation . Since functional anergy in some systems appears to reflect defective 11,2 production (30), we applied the following protocol. Responding T cell blasts were isolated from 3-d MLC and re-incubated in 11,2 containing medium for an additional 2 d. V06+/ CD4+ lymphocytes from chimeras that received B10.G bone marrow expanded -10-fold when cocultured with BALB.D2-Mlsa stimulator cells (Fig. 2) . This increased proportion of V06+/CD4+ cells was specific for Mls-1a . Lymphocytes from chimeras reconstituted with B10.S stem cells showed approximately fivefold expansion of the V06+/CD4+ subset in response to Mls-1a. Control stimulation with spleen cells from third-party C57BL/6 mice (H-2b) resulted in a proliferative response in all cases, but no specific expansion of V06+ T cells. In conclusion, these data indicate that "anergic" V06+ cells from irradiated mice reconstituted with B10.S bone marrow responded to strong Mls-1a stimulation and addition of exogenous IL2. Tolerance to Mls-1a in Chimeras Mls-1°Stimulatory Capacity ofChimeric Spleen Cells. The finding that chimeras made with I-E -donor cells remained healthy despite the presence of in vitro self-Mls-1'-reactive T cells raised the question of reactivity of V06+ T cells in vivo. Because B cells responsible for Mls-1 a stimulation (31) (32) (33) are very radiosensitive (34), we reasoned that the potentially reactive T cells may not be activated in vivo because the chimeras might lack Mls-1s stimulatory capacity, unless they had been reconstituted with bone marrow cells expressing both Mls-la and I-E determinants . To test this hypothesis, the Mls-1a reactive V06+ T cell hybrid RG17.16 was incubated with stimulator spleen cells from the various chimeras (Table 6 ). IL2 secretion was observed when stimulator cells originated from DBA/2 (I-E+, Mls-1a) mice or chimeras reconstituted with DBA/2 bone marrow. In contrast, chimeric spleen cells from Mls-1' hosts reconstituted with bone marrow from B10.G or B10.S (both I-E -and Mls-1b), or B10.D2 (I-E+, Mls-1b) donors were not stimulatory. Thus, no Mls-1 a stimulatory capacity was found in spleens of chimeras containing V06+ T cells that had escaped clonal deletion .
Discussion
The data presented herein confirm and extend recent studies (14-18) indicating that clonal deletion of self-reactive TCR Vii domains in irradiation bone marrow chimeras requires expression of I-E by donor-derived bone marrow cells. Thus, Va6+ (Mls-la-specific) cells derived from H-2q or H-2S (I-E-) bone marrow were not efficiently deleted in irradiated H-2dxq or H-2ds hosts of Mls-1a genotype. This contrasts with H-2a (I-E+) bone marrow chimeras that effectively deleted V)36+ cells in both Fl recipients . Similarly, Ramsdell et al. (16) and Roberts et al. (17) have recently shown that H-25 (I-E -) bone marrow is not effective in inducing deletion of V06+ or V017a+ cells in irradiated I-E+ recipients expressing the appropriate self-antigen (Mls-1a or I-E plus an unknown ligand for Va17a) . Collectively, these studies are compatible with the notion that in these systems clonal deletion is the result of contact between TCR on developing immature lymphocytes and self-antigens presented by I-E+ hemopoietic cells (such as B cells, dendritic cells, or macrophages) . In this model, radioresistant (presumably epithelial) cells in the thymus apparently do not contribute significantly to the deletion process.
Clonal anergy has been proposed to maintain tolerance to self-antigens in cases when clonal deletion does not (or cannot) occur (21-25) ; e.g., anergy of V06+ cells to Mls-12 has recently been demonstrated in several different experimental systems (16, 17, 19, 20) . Using irradiation bone marrow chimeras, both Ramsdell et al. (16) and Roberts et al. (17) have shown that V06+ T cells in P -> Fl chimeras derived from H-2s (I-E -) donors are selectively unresponsive to Mls-1a in vitro. The present study largely confirms these findings (in s -> d x s chimeras), although a weak response of chimeric T cells could be observed when Mls-1a was presented on MHC homozygous (d x d) stimulator cells. In striking contrast, V06+ T cells in congenic chimeras of The Mls-1--reactive T cell hybrid RG17.16 (2 x 1!04) was incubated for 48 h with stimulator spleen cells from the chimeras or control mice as indicated . Supernatants were assayed for IL-2 activity. Data are means of triplicate cultures from two individual mice.
H-2q donor bone marrow type (q --> d x q) responded strongly to host Mls-11 antigens in vitro, as assessed by proliferation and IIr2 production. The pattern of responsiveness of these chimeric T cells to a panel of stimulator cells indicated further that they were tolerant to host MHC (H-2d) but reacted to third-party allogeneic MHC. Failure of tolerance induction to host Mls-1' therefore markedly contrasts with successful tolerance induction to host MHC products. This dichotomy of reactivity to Mls-1' vs. tolerance to MHC, first demonstrated by Morrissey et al. (35) , is difficult to interpret without knowledge of the molecular structure of Mls-1' gene products. One possible explanation might be that MHC products presented by radioresistant (epithelial) thymic cells may preferentially induce clonal deletion (or functional anergy) because of their high level of expression, or because of some intrinsic property of the MHC molecules themselves. The ability of thymic epithelium to tolerize across MHC barriers is consistent with a number of tissue-grafting studies (36) (37) (38) . However, other studies on tolerance to MHC products expressed by the radioresistant component ofthe thymus have revealed tolerance in vivo but some reactivity in vitro (see references 39-48 and 49 for review) .
Induction of anergy of V06+ T cells to self Mls-1' in s --> d x s but not q --> d x q chimeras is surprising. In terms of I-E expression and ability to present Mls-1' to the Mls-1'-specific hybrid RG17.16, no quantitative differences could be found between spleen cells from the H-2 congenic d x s and d x q F, hybrid hosts utilized. Assuming these properties apply also to cells in the thymus, it seems unlikely 1311
that the differential induction of clonal anergy to Mls-11 in these chimeras can be explained by interaction ofdeveloping T cells with host components. We therefore favor the notion that donor-derived hemopoietic cells are involved in the clonal anergy phenomenon. It is noteworthy that several studies (50), including our own (29) , have recently revealed that there is a hierarchy of I-A alleles with respect to their capacity to clonally delete V)36+ cells in MHC congenic, recombinant inbred, and transgenic mouse strains of Mls-11 genotype that lack I-E expression. Thus, I-AS gene products can support a significant (although limited) deletion of V#6+ cells, whereas I-A9 gene products seem to be ineffective. Given these results, it is possible that Mls-1' is differentially "presented" on radiosensitive (hemopoietic) thymic APC expressing I-AS or I-Aq. Potential differences in the affinity of V06+ TCR for Mls-11 in association with I-AS and I-A9 may lead to anergy in one case (I-As) but not in the other (I-A9 (39) (40) (41) (42) (43) (44) (45) (46) (47) (48) (49) 51) . Despite the potential for in vitro reactivity to Mls-la, Mls-1a recipients reconstituted with H-29 bone marrow cells survived >1 yr without clinical symptoms of disease . Also, the chimeric spleen cells when adoptively transferred to irradiated Ml-1a recipients failed to provoke obvious graft-vs .-host disease (not shown) . This parallels results from similar chimeras reported by Ramsdell et al. (16) . The lack of reactivity may be interpreted as a form of "anergy" of chimeric V06+ cells in vivo. However, this may not necessarily be so, since Korngold and Sprent (52) have shown that adoptive transfer of Mls-1b spleen cells into irradiated Mls-1a recipients does not always cause lethal graft-vs .-host disease . An alternative mechanism to explain lack of pathogenic activity of Mls-1a-specific T cells in vivo may simply be the absence of appropriately presented Mls-la in these chimeras . This is suggested by the inability of chimeric spleen cells to stimulate Ilr2 production by the Mls-1a-specific T cell hybrid RG17.16 shown in Table 6 . Possibly, Va6+ cells may not be harmful in the chimeras because of inadequate Mls-1°presentation in vivo.
It is noteworthy that spleen cells from d -d x q and d -d x s chimeras, likewise, did not stimulate the Mls1a-specific hybrid RG17.16, despite the fact that effective clonal deletion of V06+ cells occurred in these animals. This finding is reminiscent of the situation observed for V011+ cells in normal mice, where clonal deletion occurs in I-E+ strains, but no in vitro reactivity to I-E+ cells can be shown (9) . Such a dissociation could reflect differential presentation of self-antigen in thymus vs. peripheral lymphoid tissue; alternatively, it is possible that the affinity threshold for clonal deletion of immature T cells is lower than that required for mature T cell activation. A third possibility to be considered in our model is that Mls-la expression may rapidly disappear after irradiation of recipient mice, thereby still fulfilling requirements of immature T cells to be tolerized but not of mature peripheral lymphocytes to be activated . Final discernment between these models most likely depends on a molecular definition of the Mls-la gene product . In summary, irradiation chimeras revealed distinct fates of V06+ T cells specific for the self-antigen Mls-1a . In the thymus, immature lymphocytes expressing V06 may have differential affinities/affinities for and/or receive differential signals from hemopoietic Mls-1a-presenting cells depending on the MHC class II molecules involved . Such interactions may apparently result in either clonal deletion, clonal anergy, or clonal responsiveness.
